FDA panel supports J&J Covid-19 vaccine booster; no vote on mixing and matching


Johnson & Johnson won the support of an FDA advisory panel, which unanimously recommended a booster shot for adults. The backing comes one day after the panel’s affirmative vote on a Moderna vaccine in a busy week of regulatory developments for Covid-19 vaccines, therapies, and diagnostics.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.